Developer of drugs for treatment of Diabetes. The company is developing a portfolio of novel drug candidates for the treatment of diabetes and related metabolic diseases.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Merger/Acquisition | 27-Aug-2015 | 00.000 | Completed | Generating Revenue | ||
1. Convertible Debt | 20-Dec-2013 | 00.000 | 00.000 | Completed | Generating Revenue |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Jaswant Gidda Ph.D | Vice President of Preclinical Development |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
5AM Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
BioCrossroads | Venture Capital | Minority | 000 0000 | 000000 0 | |
Frazier Healthcare Partners | Venture Capital | Minority | 000 0000 | 000000 0 |